SALT LAKE CITY, UT / ACCESSWIRE / October 4, 2016 / Motion Entertainment Group Inc. fka Compass Biotechnologies (OTC: COBI) is pleased to update shareholders regarding the Company's significant progress with its business growth and evolution. In the last two months, the Company has filed a name change with the Nevada Secretary of State to Motion Entertainment Group Inc. and subsequently a corporate action filing with FINRA which is expected to be made effective this week. Simultaneously, the Company has reserved the symbol "MEGA" with FINRA.

The Company has diligently worked with its partners to complete two new subsidiary agreements, specifically Motion Sound Holdings Inc. and Magic Trix Inc. The binding LOI's have been executed and the Company expects to have these definitive agreements in place within 72 hours. The subsidiaries represent the Company's shift towards the deployment of investments and the realization of growth and revenue within the entertainment sector.

"This has been a busy and fruitful period for the Company. I cannot wait to update our Shareholders about the progress that has been made in the past 60 days alone," said Interim President, Steven Smith. "We have been focused on initiating and realizing real business results, and now we are in a position to publicly announce the details."

"MEGA isn't just a symbol or name," said Smith. "It's a reflection of what we see. There is a provenance to both the products and the people within these subsidiaries, and immediate returns that we expect to create. This is an exciting time."

Steven Smith, Interim President
Motion Entertainment Group Inc. fka Compass Biotechnologies Inc.
Email: compassbiotechnologies@gmail.com
Tel: (972) 535-8931

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE: Compass Biotechnologies Inc.